http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105530940-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_05a203d85ee01909eaf728dc16f0f6cb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4709
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4709
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-10
filingDate 2014-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e65d8c12cb7a4695efb15697a658644
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70ea36d8f5c7bc49a7d93cd3b2d9157c
publicationDate 2016-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105530940-A
titleOfInvention Use of acetyl-CoA carboxylase inhibitors for the treatment of acne vulgaris
abstract The present invention relates to a method of treating and/or preventing acne in a patient comprising the step of administering to a patient in need of such treatment a therapeutically effective amount of an acetyl-CoA carboxylase (ACC) inhibitor or a pharmaceutically acceptable salt thereof.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111574530-A
priorityDate 2013-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012270893-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010204317-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465441755
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45487723

Total number of triples: 21.